Champions Oncology
CSBR
CSBR
34 hedge funds and large institutions have $51.4M invested in Champions Oncology in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+9
Holders Change %
+36%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
10
Reduced
6
Closed
1
Calls
$387K
Puts
$18K
Net Calls
+$369K
Net Calls Change
+$186K
Top Buyers
Top Sellers
| 1 |
TAM
1
Tocqueville Asset Management
New York
|
$3.47M |
| 2 |
VF
2
Virtu Financial
New York
|
$0 |
| 3 |
3
HighTower Advisors
Chicago,
Illinois
|
$305K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$4.35K |
| 5 |
5
BlackRock
New York
|
$1.01M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $66K | +$66K | +7,626 | New |
|
27
Citigroup
New York
| $42.7K | +$42.7K | +4,915 | New |
|
28
UBS Group
Zurich,
Switzerland
| $4.59K | +$4.59K | +529 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $4.35K | -$9.89K | -1,139 | -69% |
|
30
Osaic Holdings
Scottsdale,
Arizona
| $868 | – | – | – |
|
|
SS
31
SBI Securities
Tokyo,
Japan
| $139 | +$104 | +12 | +300% |
|
32
JPMorgan Chase & Co
New York
| $95 | – | – | – |
|
|
GC
33
Garde Capital
Seattle,
Washington
| $9 | +$9 | +1 | New |
|
|
VF
34
Virtu Financial
New York
| – | -$95K | -11,051 | Closed |
|